Shawn M. Sweeney

发表

Unlocking the potential of real-world evidence (RWE) in oncology - technology- and informatics-enabled solutions for clinical care, precision medicine, and discovery

Wendy S. Rubinstein, Robert S. Miller, Andrew D. Norden, 2019, AMIA.

Angiogenesis in Collagen I Requires α2β1 Ligation of a GFP*GER Sequence and Possibly p38 MAPK Activation and Focal Adhesion Disassembly*

Shawn M. Sweeney, Gregg B. Fields, Renato V. Iozzo, 2003, Journal of Biological Chemistry.

Mapping the Ligand-binding Sites and Disease-associated Mutations on the Most Abundant Protein in the Human, Type I Collagen*

Shawn M. Sweeney, L. Ala‐Kokko, S. Sweeney, 2002, The Journal of Biological Chemistry.

Endorepellin, a Novel Inhibitor of Angiogenesis Derived from the C Terminus of Perlecan*

Shawn M. Sweeney, R. Iozzo, Jian-Lin Fu, 2003, The Journal of Biological Chemistry.

Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development.

Feiyan Liu, Lan Cheng, Shawn M. Sweeney, 2006, Developmental cell.

Versatility of BCR/ABL-expressing leukemic cells in circumventing proapoptotic BAD effects.

Shawn M. Sweeney, B. Calabretta, P. Salomoni, 2000, Blood.

Defining the domains of type I collagen involved in heparin- binding and endothelial tube formation.

Shawn M. Sweeney, G. Fields, S. Sweeney, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Candidate Cell and Matrix Interaction Domains on the Collagen Fibril, the Predominant Protein of Vertebrates*

Shawn M. Sweeney, L. Ala‐Kokko, A. Fertala, 2008, Journal of Biological Chemistry.

Angiogenesis in collagen I requires alpha2beta1 ligation of a GFP*GER sequence and possibly p38 MAPK activation and focal adhesion disassembly.

Shawn M. Sweeney, R. Iozzo, G. Fields, 2003, The Journal of biological chemistry.

Type I collagen-heparin interactions in angiogenesis

Shawn M. Sweeney, G. Fields, C. Fields, 1997 .

Erratum: Regulation of cardiovascular development and integrity by the heart of glass- cerebral cavernous malformation protein pathway (Natural Medical (2007) 15 (169-176))

Shawn M. Sweeney, M. Lu, M. Affolter, 2009 .